Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Brown, A. S. Articles by Susser, E. S. Search for Related Content PubMed Citation Articles by Brown, A. S. Articles by Susser, E. S. Gender Schizophrenia Spectrum Disorders Neurodevelopment

Maternal Exposure to Toxoplasmosis and Risk of Schizophrenia in Adult Offspring

OBJECTIVE: The authors examined the relationship between maternal antibody to toxoplasmosis and the risk of schizophrenia and other schizophrenia spectrum disorders in offspring. Toxoplasmosis is known to adversely affect fetal brain development. METHOD: In a nested case-control design of a large birth cohort born between 1959 and 1967, the authors conducted serological assays for Toxoplasma antibody on maternal serum specimens from pregnancies giving rise to 63 cases of schizophrenia and other schizophrenia spectrum disorders and 123 matched comparison subjects. Toxoplasma immunoglobulin (Ig)G antibody was quantified by using the Sabin-Feldman dye test. The Ig titers were classified into three groups: negative (<1:16) (reference), moderate (1:16–1:64), and high (1:128). RESULTS: The adjusted odds ratio of schizophrenia/schizophrenia spectrum disorders for subjects with high maternal Toxoplasma IgG antibody titers was 2.61 (95% confidence interval=1.00–6.82). There was no association between moderate Toxoplasma Ig antibody titers and the risk of schizophrenia/spectrum disorders. CONCLUSIONS: These findings suggest that maternal exposure to toxoplasmosis may be a risk factor for schizophrenia. The findings may be explained by reactivated infection or an effect of the antibody on the developing fetus. Given that toxoplasmosis is a preventable infection, the findings, if replicated, may have implications for reducing the incidence of schizophrenia.

This article has been cited by other articles:

				U. Meyer, J. Feldon, and B. K. Yee A Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia Schizophr Bull, September 1, 2009; 35(5): 959 - 972. [Abstract] [Full Text] [PDF]

				E. G. Severance, F. B. Dickerson, R. P. Viscidi, I. Bossis, C. R. Stallings, A. E. Origoni, A. Sullens, and R. H. Yolken Coronavirus Immunoreactivity in Individuals With a Recent Onset of Psychotic Symptoms Schizophr Bull, June 2, 2009; (2009) sbp052v1. [Abstract] [Full Text] [PDF]

				T. E. Goldberg and J. J. Gomar Targeting Cognition in Schizophrenia Research: From Etiology to Treatment Am J Psychiatry, June 1, 2009; 166(6): 631 - 634. [Full Text] [PDF]

				A. S. Brown, S. Vinogradov, W. S. Kremen, J. H. Poole, R. F. Deicken, J. D. Penner, I. W. McKeague, A. Kochetkova, D. Kern, and C. A. Schaefer Prenatal Exposure to Maternal Infection and Executive Dysfunction in Adult Schizophrenia Am J Psychiatry, June 1, 2009; 166(6): 683 - 690. [Abstract] [Full Text] [PDF]

				J. Welham, M. Isohanni, P. Jones, and J. McGrath The Antecedents of Schizophrenia: A Review of Birth Cohort Studies Schizophr Bull, May 1, 2009; 35(3): 603 - 623. [Abstract] [Full Text] [PDF]

				H. J. Sorensen, E. L. Mortensen, J. M. Reinisch, and S. A. Mednick Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia Schizophr Bull, May 1, 2009; 35(3): 631 - 637. [Abstract] [Full Text] [PDF]

				D. W. Niebuhr, A. M. Millikan, R. Yolken, Y. Li, and N. S. Weber Results From a Hypothesis Generating Case-Control Study: Herpes Family Viruses and Schizophrenia Among Military Personnel Schizophr Bull, November 1, 2008; 34(6): 1182 - 1188. [Abstract] [Full Text] [PDF]

				V. A. Mittal, L. M. Ellman, and T. D. Cannon Gene-Environment Interaction and Covariation in Schizophrenia: The Role of Obstetric Complications Schizophr Bull, November 1, 2008; 34(6): 1083 - 1094. [Abstract] [Full Text] [PDF]

				C. Dalman, P. Allebeck, D. Gunnell, G. Harrison, K. Kristensson, G. Lewis, S. Lofving, F. Rasmussen, S. Wicks, and H. Karlsson Infections in the CNS During Childhood and the Risk of Subsequent Psychotic Illness: A Cohort Study of More Than One Million Swedish Subjects Am J Psychiatry, January 1, 2008; 165(1): 59 - 65. [Abstract] [Full Text] [PDF]

				D. W. Niebuhr, A. M. Millikan, D. N. Cowan, R. Yolken, Y. Li, and N. S. Weber Selected Infectious Agents and Risk of Schizophrenia Among U.S. Military Personnel Am J Psychiatry, January 1, 2008; 165(1): 99 - 106. [Abstract] [Full Text] [PDF]

				J. L. Jones, D. Kruszon-Moran, K. Sanders-Lewis, and M. Wilson Toxoplasma gondii Infection in the United States, 1999 2004, Decline from the Prior Decade Am J Trop Med Hyg, September 1, 2007; 77(3): 405 - 410. [Abstract] [Full Text] [PDF]

				W. Veling, J.-P. Selten, E. Susser, W. Laan, J. P Mackenbach, and H. W Hoek Discrimination and the incidence of psychotic disorders among ethnic minorities in The Netherlands Int. J. Epidemiol., August 1, 2007; 36(4): 761 - 768. [Abstract] [Full Text] [PDF]

				E. F. Torrey, J. J. Bartko, Z.-R. Lun, and R. H. Yolken Antibodies to Toxoplasma gondii in Patients With Schizophrenia: A Meta-Analysis Schizophr Bull, May 1, 2007; 33(3): 729 - 736. [Abstract] [Full Text] [PDF]

				F. Dickerson, J. Boronow, C. Stallings, A. Origoni, and R. Yolken Toxoplasma gondii in Individuals With Schizophrenia: Association With Clinical and Demographic Factors and With Mortality Schizophr Bull, May 1, 2007; 33(3): 737 - 740. [Abstract] [Full Text] [PDF]

				P. B. Mortensen, B. Norgaard-Pedersen, B. L. Waltoft, T. L. Sorensen, D. Hougaard, and R. H. Yolken Early Infections of Toxoplasma gondii and the Later Development of Schizophrenia Schizophr Bull, May 1, 2007; 33(3): 741 - 744. [Abstract] [Full Text] [PDF]

				J. J. McGrath The Surprisingly Rich Contours of Schizophrenia Epidemiology Arch Gen Psychiatry, January 1, 2007; 64(1): 14 - 16. [Full Text] [PDF]

				A. S. Brown, C. A. Schaefer, C. P. Quesenberry Jr., L. Shen, and E. S. Susser No Evidence of Relation Between Maternal Exposure to Herpes Simplex Virus Type 2 and Risk of Schizophrenia? Am J Psychiatry, December 1, 2006; 163(12): 2178 - 2180. [Abstract] [Full Text] [PDF]

				C. B. Pedersen and P. B. Mortensen Are the Cause(s) Responsible for Urban-Rural Differences in Schizophrenia Risk Rooted in Families or in Individuals? Am. J. Epidemiol., June 1, 2006; 163(11): 971 - 978. [Abstract] [Full Text] [PDF]

				V. Babulas, P. Factor-Litvak, R. Goetz, C. A. Schaefer, and A. S. Brown Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia Am J Psychiatry, May 1, 2006; 163(5): 927 - 929. [Abstract] [Full Text] [PDF]

				A. S Brown Prenatal Infection as a Risk Factor for Schizophrenia Schizophr Bull, April 1, 2006; 32(2): 200 - 202. [Abstract] [Full Text] [PDF]

				M. C. Clarke, M. Harley, and M. Cannon The Role of Obstetric Events in Schizophrenia Schizophr Bull, January 1, 2006; 32(1): 3 - 8. [Full Text] [PDF]

				L. B Dunn, P. J Candilis, and L. W. Roberts Emerging Empirical Evidence on the Ethics of Schizophrenia Research Schizophr Bull, January 1, 2006; 32(1): 47 - 68. [Abstract] [Full Text] [PDF]

				A. Levin Can Parasite in Mothers Lead To Schizophrenia? Psychiatr News, May 6, 2005; 40(9): 30 - 52. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us